Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae

支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析

基本信息

  • 批准号:
    10219082
  • 负责人:
  • 金额:
    $ 74.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-17 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The increasing rate of infection and spread of antibiotic resistance in Neisseria gonorrhoeae poses an urgent threat to public health. Knowledge of the pathways and genes that support the emergence and spread of antibi- otic resistance is necessary to develop new strategies for surveillance, diagnosis, and treatment. Despite our understanding of the genes and alleles that confer resistance, significant knowledge gaps remain regarding the factors that contribute to the uneven distribution of resistance across the gonococcal species phylogeny. A core issue that remains poorly explored is the impact of resistance determinants on gonococcal fitness: to what extent do resistance determinants impact fitness, and, if they incur a fitness cost, how does the gonococcus adapt and mitigate these costs? In this proposal, we address these gaps through a comprehensive strategy linking experi- mental and computational identification of compensatory mutations with studies of their mechanisms of action. The overall goal of this project is to determine the impact of mutations that increase resistance to the two most clinically relevant antibiotics for treatment of gonorrhea, ciprofloxacin and ceftriaxone, on bacterial fitness. We will achieve this goal through three specific aims. In Aim 1, we will determine the fitness costs of resistance alleles when transformed into susceptible isolates from different niches and with distinct phylogeny and identify compensatory mutations that mitigate these fitness costs through experimental evolution in the female mouse model. We will examine the two most common ciprofloxacin resistance-conferring alleles (gyrAS91F,D95G and parCS87R) in clinical isolates, and four ceftriaxone resistance-conferring alleles (two variants of penA, the lethal target of ceftriaxone, and newly described variants in rpoB and rpoD), and evaluate the dependence of compen- satory pathways on genomic background. In Aim 2, we will leverage our collection of over 7500 gonococcal genomes from clinical isolates for which we have antibiotic-resistance phenotypes and employ population ge- nomics methods to identify potential compensatory mutations and test these in the mouse model. Moreover, we will define the allelic diversity and distribution of candidates identified in Aim 1. In Aim 3, we will determine the mechanism of action of confirmed compensatory mutations arising from the studies in Aims 1 & 2 using an integrative strategy that examines growth and morphology, transcriptomics, metabolomics, and directed studies of biochemical function. We will also build on preliminary data on compensatory mutations in acnB and mleN for ceftriaxone resistance and on the thiamine biosynthesis pathway in gyrA-mediated quinolone resistance. This interdisciplinary project brings together the complementary and non-overlapping expertise of three lead- ing investigators in the biology and genetics of antibiotic resistance in N. gonorrhoeae, linking the mouse model of gonococcal infection (Dr. Jerse), population genomics (Dr. Grad), and biochemical and physiological charac- terization of resistance-related variants (Dr. Nicholas).
项目概要 淋病奈瑟菌感染率的增加和抗生素耐药性的传播提出了一个紧迫的问题 对公众健康的威胁。了解支持抗生素出现和传播的途径和基因 耳阻力对于制定新的监测、诊断和治疗策略是必要的。尽管我们的 尽管对赋予抗性的基因和等位基因的了解,但在抗药性方面仍存在重大知识差距 导致淋球菌物种系统发育中耐药性分布不均匀的因素。一个核心 尚未充分探讨的问题是耐药性决定因素对淋球菌适应性的影响:影响到什么程度 抵抗力决定因素会影响健康吗?如果它们会产生健康成本,淋球菌如何适应和 减轻这些成本?在本提案中,我们通过一项综合战略来解决这些差距 补偿性突变的心理和计算识别及其作用机制的研究。 该项目的总体目标是确定增加对这两种病毒的抵抗力的突变的影响 用于治疗淋病的最临床相关抗生素是环丙沙星和头孢曲松,对细菌适应性有影响。 我们将通过三个具体目标来实现这一目标。在目标 1 中,我们将确定阻力的适应成本 当转化为来自不同生态位且具有不同系统发育的易感分离株时,等位基因可被识别 通过雌性小鼠的实验进化来减轻这些适应性成本的补偿性突变 模型。我们将检查两个最常见的环丙沙星耐药性等位基因(gyrAS91F、D95G 和 parCS87R),以及四个头孢曲松耐药性等位基因(penA 的两个变体,致命的 头孢曲松的目标,以及新描述的 rpoB 和 rpoD 变体),并评估补偿的依赖性 基因组背景上的饱和途径。在目标 2 中,我们将利用我们收集的 7500 多种淋球菌 来自临床分离株的基因组,我们对其具有抗生素抗性表型并采用群体基因组 识别潜在补偿性突变并在小鼠模型中测试这些突变的经济学方法。此外,我们 将定义目标 1 中确定的候选者的等位基因多样性和分布。在目标 3 中,我们将确定 目的 1 和 2 的研究证实了补偿性突变的作用机制,使用 检查生长和形态、转录组学、代谢组学和定向研究的综合策略 的生化功能。我们还将建立关于 acnB 和 mleN 补偿突变的初步数据 头孢曲松耐药性以及gyrA介导的喹诺酮耐药性中硫胺素生物合成途径的影响。 这个跨学科项目汇集了三位领导者互补且不重叠的专业知识 淋病奈瑟菌抗生素耐药性的生物学和遗传学研究人员将小鼠模型联系起来 淋球菌感染(Jerse 博士)、群体基因组学(Grad 博士)以及生化和生理特征 耐药相关变异的特化(尼古拉斯博士)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yonatan H Grad其他文献

emNeisseria gonorrhoeae/em diagnostic escape from a emgyrA/em-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study
淋病奈瑟菌对基于 gyrA 的环丙沙星敏感性检测的诊断逃逸及对唑立复林耐药性的影响:一项细菌遗传学和实验进化研究
  • DOI:
    10.1016/s2666-5247(22)00356-1
  • 发表时间:
    2023-04-01
  • 期刊:
  • 影响因子:
    20.400
  • 作者:
    Daniel HF Rubin;Tatum D Mortimer;Yonatan H Grad
  • 通讯作者:
    Yonatan H Grad
Modelling molecular and culture-based surveillance of tetracycline resistance in emNeisseria gonorrhoeae/em
淋病奈瑟菌四环素耐药性基于分子和培养的监测模型
  • DOI:
    10.1016/s1473-3099(24)00408-0
  • 发表时间:
    2024-08-01
  • 期刊:
  • 影响因子:
    31.000
  • 作者:
    Kirstin I Oliveira Roster;Rachel Mittelstaedt;Jordan Reyes;Aishani V Aatresh;Yonatan H Grad
  • 通讯作者:
    Yonatan H Grad
Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
美国退伍军人事务医疗保健系统感染发生率和抗菌药物耐药性趋势:一项全国性回顾性队列研究(2007-22 年)
  • DOI:
    10.1016/s1473-3099(24)00416-x
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
    31.000
  • 作者:
    Thi Mui Pham;Yue Zhang;McKenna Nevers;Haojia Li;Karim Khader;Yonatan H Grad;Marc Lipsitch;Matthew Samore
  • 通讯作者:
    Matthew Samore
Biodiversity and hypervirulence of Listeria monocytogenes
单核细胞增生李斯特菌的生物多样性和超强毒性
  • DOI:
    10.1038/ng.3515
  • 发表时间:
    2016-02-24
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Yonatan H Grad;Sarah M Fortune
  • 通讯作者:
    Sarah M Fortune

Yonatan H Grad的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yonatan H Grad', 18)}}的其他基金

Genetic modulators of serum resistance in Neisseria gonorrhoeae
淋病奈瑟菌血清抗性的遗传调节剂
  • 批准号:
    10608700
  • 财政年份:
    2023
  • 资助金额:
    $ 74.84万
  • 项目类别:
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
  • 批准号:
    10443593
  • 财政年份:
    2020
  • 资助金额:
    $ 74.84万
  • 项目类别:
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
  • 批准号:
    10034093
  • 财政年份:
    2020
  • 资助金额:
    $ 74.84万
  • 项目类别:
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
支持淋病奈瑟菌抗生素耐药性进化的补偿突变的鉴定和分析
  • 批准号:
    10650744
  • 财政年份:
    2020
  • 资助金额:
    $ 74.84万
  • 项目类别:
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeae
阐明淋病奈瑟菌抗生素耐药性途径的基因组学方法
  • 批准号:
    10736734
  • 财政年份:
    2017
  • 资助金额:
    $ 74.84万
  • 项目类别:
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeae
阐明淋病奈瑟菌抗生素耐药性途径的基因组学方法
  • 批准号:
    9367004
  • 财政年份:
    2017
  • 资助金额:
    $ 74.84万
  • 项目类别:
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeae
阐明淋病奈瑟菌抗生素耐药性途径的基因组学方法
  • 批准号:
    10190792
  • 财政年份:
    2017
  • 资助金额:
    $ 74.84万
  • 项目类别:
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefixime
头孢克肟 MIC 升高的淋病奈瑟菌的基因组流行病学
  • 批准号:
    8862369
  • 财政年份:
    2013
  • 资助金额:
    $ 74.84万
  • 项目类别:
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefixime
头孢克肟 MIC 升高的淋病奈瑟菌的基因组流行病学
  • 批准号:
    9005937
  • 财政年份:
    2013
  • 资助金额:
    $ 74.84万
  • 项目类别:
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefixime
头孢克肟 MIC 升高的淋病奈瑟菌的基因组流行病学
  • 批准号:
    8487485
  • 财政年份:
    2013
  • 资助金额:
    $ 74.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 74.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了